Clinical Trials Directory

Trials / Sponsors / Shanghai Zerun Biotechnology Co.,Ltd

Shanghai Zerun Biotechnology Co.,Ltd

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingLong-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women
Cervical Cancer, Vulvar Cancer, Vaginal Cancer
—2023-03-27
UnknownPhase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9
Cervical Cancer, Genital Wart, CIN
Phase 32022-09-01
UnknownEvaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.
SARS-CoV-2 Infection, COVID-19
Phase 1 / Phase 22022-06-02
UnknownSafety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COV
COVID-19
Phase 1 / Phase 22022-01-18
UnknownPhase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID
COVID-19
Phase 22021-07-31
UnknownPhase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-
COVID-19
Phase 12021-07-12
CompletedLot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females
HPV Infection
Phase 32021-04-20
CompletedA Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine
HPV Infections
Phase 12019-03-09
CompletedEvaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
Human Papillomavirus, Cervical Intraepithelial Neoplasia, Persistent Infection
Phase 22016-02-01
CompletedA Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Cervical Intraepithelial Neoplasia
Phase 32014-11-02
CompletedImmunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females
Human Papillomavirus
Phase 22013-09-01
UnknownEvaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy
Human Papillomavirus
Phase 12012-02-01